Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations

Peer Review reports

Original Submission
8 Aug 2020	Submitted	Original manuscript
20 Oct 2020	Reviewed	Reviewer Report - Alexander Kaizer
9 Nov 2020	Reviewed	Reviewer Report - Roberta Littleford
20 Dec 2020	Author responded	Author comments - UPMC REMAP-COVID Group, on behalf of the REMAP-CAP Investigators
Resubmission - Version 2
20 Dec 2020	Submitted	Manuscript version 2
Publishing
22 Dec 2020	Editorially accepted
28 Jan 2021	Article published	10.1186/s13063-020-04997-6

Back to article page